Duhao Net helps individual entrepreneurs and enterprises find high-quality suppliers, reduce procurement costs, and make transactions easier.

Hebei Zhitong Biopharmaceutical Co., Ltd.: Chinese peptide drug manufacturer

Release time：2024-09-27 21:08:07 Source：DuHao

Tel : +86-0311-66571903

Email: net.fei@163.com

Address: No. 1 Gucheng, Dingxing County, Baoding City, Hebei Province, China

Founded in 1998, Hebei Zhitong Biopharmaceutical Co., Ltd. is a high-tech enterprise located in Dingxing County, Baoding City, Hebei Province, China. The company specializes in peptide extraction technology and is involved in the research, development, production, and sale of high-end chemical drugs. Together with its subsidiaries, Hebei Aierhaitai Pharmaceutical Co., Ltd. and Hebei Qianfan Pharmaceutical Sales Co., Ltd., Hebei Zhitong has built a reputation for innovation in the pharmaceutical industry. It is one of the first companies to be recognized as a "specialized, refined, and innovative" small giant enterprise by the Ministry of Industry and Information Technology of China and is a major project undertaking unit under the 13th Five-Year Plan of the country.

The company's strategic location in Dingxing County, near Xiong'an New Area, offers excellent access to the Beijing, Tianjin, and Baoding economic hubs. This prime positioning allows Hebei Zhitong to capitalize on the region’s robust infrastructure and business ecosystem, facilitating its growth and market reach.

Facilities and Team

The production facilities span 26,607 square meters, with a registered capital of 127.5 million yuan. The company boasts a highly skilled management and technical team, driving its success in the pharmaceutical industry.

Products and Technology

Hebei Zhitong's product portfolio includes 73 drug varieties with 121 specifications, addressing critical disease areas such as the nervous system, musculoskeletal system, respiratory system, cardiovascular system, and digestive tract. The company excels in cutting-edge peptide drug research, focusing on creating high-value-added products with independent intellectual property rights. Over the years, it has developed four core technology platforms:

Peptide Drugs and Peptide Nutritional Food Technology Platform
Liquid Hard Capsule Preparation Technology Platform
Ergot Alkaloid Technology Platform
Chemical Drug Industrialization Technology Platform

These platforms provide a solid foundation for new product development, technological advancements, and dosage form innovation.

Vision: To drive breakthroughs in new drug technology, leading the development of small-molecule peptide drugs, and becoming a leading company in China’s small-molecule peptide pharmaceutical industry.

Mission: Focus on human health, and use technology to protect life.

Core Values

Technology Leadership

Ambition

Product Focus

Hebei Zhitong's product offerings include a variety of drugs and nutritional supplements:

Brain Polypeptide Nutrient Solution: A drink designed for neurological health.

Spleen Polypeptide Nutrient Solution and Injection: Used for immune regulation and tumor inhibition, derived from pig spleen tissue to provide small molecule polypeptides for easy absorption.

Compound Bone Peptide for Injection: A preparation made from pig limb bones and scorpions, promoting fracture healing and treating diseases like rheumatoid arthritis and osteoporosis.

Research and Development

The company invests heavily in R&D to enhance the effectiveness of its products. For instance, studies on compound bone peptide for injection show its effectiveness in increasing bone morphogenetic proteins (BMPs) and transforming growth factor (TGF-β1), critical for bone healing and anti-inflammatory processes. These advancements reflect the company’s commitment to innovation and improving patient outcomes.

Hebei Zhitong Biopharmaceutical Co., Ltd. aims to continue its pioneering work in peptide drug development, exploring new frontiers in pharmaceutical technology to meet the evolving needs of the healthcare industry.

Duhao Net